Navigation Links
Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025
Date:2/9/2010

LAUSANNE, Switzerland, February 9 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect. The product is currently in phase 2b clinical development for the treatment of hepatitis C. Debiopharm granted Novartis worldwide commercialisation rights to Debio 025 except for Japan.

Under the terms of the agreement, Novartis will pay Debiopharm an upfront, development and sales milestones as well as royalties. This transaction is subject to customary regulatory approvals.

According to the World Health Organization 170 million people suffer from HCV in the world. "Sadly only 20% of those patients are treated adequately," said Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "At Debiopharm, we have a strong commitment to providing HCV sufferers with an efficacious cure and are confident about the potential of an innovative, first-in-class compound such as Debio 025, which may represent a breakthrough in the treatment of Hepatitis C. We are very happy to be working alongside Novartis, a partner with a strong dedication to HCV."

About Debio 025

Debio 025 is an oligopeptide that has some chemical features in common with cyclosporine A, but is devoid of its immunosuppressive pharmacological effects. It has a very potent inhibitory effect on HCV replication both in vitro and in vivo. Debio 025 has excellent antiviral activity
'/>"/>

SOURCE Debiopharm Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
2. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
3. Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
4. Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
5. Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
6. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
7. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
8. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
9. Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call
10. PSKW & Associates LLC Acquires Triax Media, Licenses Triax to Subsidiary, Centricity Group
11. Foundation Radiology Group Announces FRG Molecular Imaging Division, Led By Todd M. Blodgett, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Landscape Poland " an essential source of information ... market and provides insights into the demographic, regulatory, ... report provides valuable insights into the trends and ...
(Date:8/28/2014)... Aug. 28, 2014 Tianyin Pharmaceutical Co., ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today updates the timeline for ... (QLF). The Company is scheduled ... for China Food & Drug Administration,s (CFDA) review ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Academy Leadership, ... service academy graduates, has published a case study ... Leadership Excellence Course . In September and October ... Course to Albuquerque , Indianapolis , ... Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... ROCKVILLE, Md. , Jan. 28 A ... benefits and risks of implantable cardioverter defibrillators (ICDs) in patients ... by HHS, Agency for Healthcare Research and Quality and the ... project is being conducted in cooperation with the National Heart, ...
... BOCA RATON, Fla. , Jan. 28 ... leader in portable electronic medical records management, today announced that ...  The companies will collaborate on initiatives directed to U.S. seniors ... solution. , The Senior Site, Inc. caters to an extremely ...
Cached Medicine Technology:AHRQ and American College of Cardiology Collaborate On Study of Implantable Cardioverter Defibrillators 2MedeFile Makes Strides with the Senior Market 2MedeFile Makes Strides with the Senior Market 3MedeFile Makes Strides with the Senior Market 4MedeFile Makes Strides with the Senior Market 5
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 Millennium ... use affecting users in the workplace. A recent ... Dependence (NCADD) states that drug abuse is costing ... who use or are addicted to drugs affect their ... activities carry over into the workplace, causing expensive problems ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, 2014 (HealthDay ... symptoms of multiple sclerosis (MS), a new study from Argentina ... D, smoking and Epstein Barr virus infection. Our study shows ... MS patients," said lead researcher Dr. Mauricio Farez, of the ... Multiple sclerosis is a disease of the nervous system that ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Testimony ... trial of a transvaginal mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ ... Bernstein Liebhard LLP reports. Court documents pending in ... Virginia indicate that the case was filed on ... two revision surgeries, allegedly due to vaginal mesh ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 ... Nutrition announced today a regional partnership designed to ... goal planning for competitive young athletes, scholastic athletes ... “Our partnership’s Strong Body & Mind Initiative will ... addresses both the physical and mental dynamics involved ...
(Date:8/28/2014)... Sterling Heights, MI (PRWEB) August 28, 2014 ... stagnated in the last year, down by 0.13% in real ... G7, according to a new study by UHY, the international ... for the US’s small businesses in particular, the credit crunch ... in lending in last the last year have been wiped ...
Breaking Medicine News(10 mins):Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 2Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 3Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 4Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 5Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 6Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 7
... Corp. ("Echo" or the "Company") (OTC Bulletin Board: ... meeting of stockholders today,that the polls will remain ... vote on the proposed merger transaction with XLNT,Veterinary ... forth in the,proxy statement/prospectus previously mailed to Echo ...
... The California Nurses,Association/National Nurses Organizing Committee today ... liver transplant one week earlier for,17-year-old Nataline Sarkisyan, ... relented and agreed to the procedure following a ... physicians, including the surgical director of,the Pediatric Liver ...
... EPA, National Contest Urges Young People to Promote ... National Safety,Council has named the winners of its ... the United States Environmental Protection,Agency. First-place winner is ... Arts & Science in Hollywood, Florida; second-place winner ...
... of a songbird may appear effortless, but his elocutions ... youth and maintained throughout adulthood. His tune has virtually ... the motor performance of top athletes and musicians. Yet, ... songbirds and humans. Now, scientists think they know why. ...
... Partnership Co-led by Founder and CEO Dennis Gillings, Bain ... ... Dec. 21 Quintiles,Transnational Corp. today announced the formation of a ... current Chairman and CEO Dennis Gillings, CBE, and the management team.,Gillings ...
... MASI ), the inventor of Pulse CO-Oximetry and ... it is scheduled to,present at the 26th Annual JPMorgan ... CA on Monday, January 7, 2008 at 8:30 a.m. ... de Raad, Executive Vice,President and CFO, will be presenting., ...
Cached Medicine News:Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 2Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 3Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 4Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 5Health News:RN's Statement on Death of Nataline Sarkisyan: 'CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago' 2Health News:National Safety Council Names Winners of Radon Poster Contest 2Health News:Songbirds offer clues to highly practiced motor skills in humans 2Health News:Songbirds offer clues to highly practiced motor skills in humans 3Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 2Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 3Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 4Health News:Masimo to Present at 26th Annual JPMorgan Healthcare Conference 2
Stryker bariatric laparoscopes set the standard in picture quality....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
... Bactron I is an ... designed for use by smaller ... as an economical set-up station ... quality features of other Bactron ...
Medicine Products: